11:12 AM EST, 01/31/2025 (MT Newswires) -- AstraZeneca ( AZN ) has cancelled a plan to invest 450 million pounds ($558.3 million) in a UK vaccine manufacturing plant in Liverpool.

Reduced UK government support is the main reason for withdrawing from the Speke facility development, the company said.

"Several factors have influenced this decision, including the timing and reduction of the final offer compared to the previous government's proposal," a company spokesperson said.

Despite the change in plans, the plant in Liverpool will continue to produce the company's flu vaccine, AstraZeneca ( AZN ) said.

Price: 70.92, Change: -0.32, Percent Change: -0.45